TY - JOUR
T1 - Carbon monoxide toxicity
T2 - A case series
AU - Berent, Allyson C.
AU - Todd, Jeffrey
AU - Sergeeff, Jennifer
AU - Powell, Lisa L.
PY - 2005/6
Y1 - 2005/6
N2 - Objective: To describe diagnostics, therapy, and sequelae of acute carbon monoxide (CO) toxicity because of a motor vehicle generator in 4 dogs and 2 cats. Series summary: Four dogs and 2 cats presented for recumbency, disorientation, dyspnea, and stiffness after an estimated 6-8 hour exposure to exhaust from a generator. Diagnostics included a serum carboxyhemoglobin levels evaluation, arterial blood gas analysis, pulse oximetry readings, and blood pressure measurements. Initial therapy included oxygen (O2) administration, intravenous bronchodilators, fluids, and a hemoglobin-based O2 carrying (HBOC) molecule. Following administration of the HBOC, 4 of the 6 animals showed dramatic clinical improvement. Two weeks after hospital discharge, the owner reported potential hearing deficits in all animals. Brain auditory evoked response (BAER) tests were conducted in all surviving animals and some degree of hearing impairment was documented in all cases, with complete clinical resolution noted 6 weeks later. Unique information provided: This report describes the therapeutic use of an HBOC in acute isolated CO toxicity (i.e. without the complications of smoke inhalation). In addition, delayed nervous system dysfunction was documented in all surviving animals.
AB - Objective: To describe diagnostics, therapy, and sequelae of acute carbon monoxide (CO) toxicity because of a motor vehicle generator in 4 dogs and 2 cats. Series summary: Four dogs and 2 cats presented for recumbency, disorientation, dyspnea, and stiffness after an estimated 6-8 hour exposure to exhaust from a generator. Diagnostics included a serum carboxyhemoglobin levels evaluation, arterial blood gas analysis, pulse oximetry readings, and blood pressure measurements. Initial therapy included oxygen (O2) administration, intravenous bronchodilators, fluids, and a hemoglobin-based O2 carrying (HBOC) molecule. Following administration of the HBOC, 4 of the 6 animals showed dramatic clinical improvement. Two weeks after hospital discharge, the owner reported potential hearing deficits in all animals. Brain auditory evoked response (BAER) tests were conducted in all surviving animals and some degree of hearing impairment was documented in all cases, with complete clinical resolution noted 6 weeks later. Unique information provided: This report describes the therapeutic use of an HBOC in acute isolated CO toxicity (i.e. without the complications of smoke inhalation). In addition, delayed nervous system dysfunction was documented in all surviving animals.
KW - Carboxyhemoglobin
KW - Delayed nervous system dysfunction
KW - Dysacousis
KW - Hemoglobin-based oxygen carrying molecule
UR - http://www.scopus.com/inward/record.url?scp=27644549506&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27644549506&partnerID=8YFLogxK
U2 - 10.1111/j.1476-4431.2005.00140.x
DO - 10.1111/j.1476-4431.2005.00140.x
M3 - Article
AN - SCOPUS:27644549506
SN - 1479-3261
VL - 15
SP - 128
EP - 135
JO - Journal of Veterinary Emergency and Critical Care
JF - Journal of Veterinary Emergency and Critical Care
IS - 2
ER -